Metronomic oral cyclophosphamide prednisolone chemotherapy is an effective treatment for metastatic hormone-refractory prostate cancer after docetaxel failure.
Year: 2010
Type: article
Study design: Clinical Trial
Source: PubMed
Institutions: Inserm, Centre Georges François Leclerc
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2188158235
